In today’s fast-paced, technology-driven world, businesses face an ever-increasing demand for efficiency, productivity, and innovation. The global landscape is rapidly evolving, and companies that do ...
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...
A growing number of economists are calling on governments to step up to ensure that the private sector’s pursuit of profit is ...
About seven years ago, representatives of bKash would visit the company’s agent points and merchant outlets across Bangladesh ...
More than 15 anesthesia leaders — anesthesiologists and certified registered nurse anesthetists — joined Becker's to discuss how the anesthesia workforce will evolve over the next five years. Question ...
The FDA announcement confirms that the U.S. supply of both prescription-only drugs now meets or exceeds the current and ...
Oil prices fell on Friday but were still poised for a weekly gain on supply disruption in Russia while uncertainty looms over ...
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.
The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...
Novo Nordisk's (NVO) weight loss therapy Wegovy/Ozempic come out of shortage, but the FDA won't crack down on compounders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback